The Phenotype Changes of Astrocyte During Different Ischemia Conditions

Objectives: Dementia is becoming a major health problem in the world, and chronic brain ischemia is an established important risk factor in predisposing this disease. Astrocytes, as one major part of the blood–brain barrier (BBB), are activated during chronic cerebral blood flow hypoperfusion. React...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei Meng, Jing Cui, Peng Wang, Junhui Wang, Jing Sun, Liang Li
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/14/12/1256
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846105481390587904
author Fei Meng
Jing Cui
Peng Wang
Junhui Wang
Jing Sun
Liang Li
author_facet Fei Meng
Jing Cui
Peng Wang
Junhui Wang
Jing Sun
Liang Li
author_sort Fei Meng
collection DOAJ
description Objectives: Dementia is becoming a major health problem in the world, and chronic brain ischemia is an established important risk factor in predisposing this disease. Astrocytes, as one major part of the blood–brain barrier (BBB), are activated during chronic cerebral blood flow hypoperfusion. Reactive astrocytes have been classified into phenotype pro-inflammatory type A1 or neuroprotective type A2. However, the specific subtype change of astrocyte and the mechanisms of chronic brain ischemia are still unknown. Methods: In order to depict the phenotype changes and their possible roles during this process, a rat bilateral common carotid artery occlusion model (BCAO) was employed in the present study. Meanwhile, the signaling pathways that possibly regulate these changes were investigated as well. Results: After four-week occlusion, astrocytes in the cortex of BCAO rats were shown to be the A2 phenotype, identified by the significant up-regulation of S100a10 accompanied by the down-regulation of Connexin 43 (CX43) protein. Next, we established in vitro hypoxia models, which were set up by stimulating primary astrocyte cultures from rat cortex with cobalt chloride, low glucose, or/and fibrinogen. Consistent with in vivo data, the cultured astrocytes also transformed into the A2 phenotype with the up-regulation of S100a10 and the down-regulation of CX43. In order to explore the mechanism of CX43 protein changes, C6 astrocyte cells were handled in both hypoxia and low-glucose stimulus, in which decreased pERK and pJNK expression were found. Conclusions: In conclusion, our data suggest that in chronic cerebral ischemia conditions, the gradual ischemic insults could promote the transformation of astrocytes into A2 type instead of A1 type, and the phosphorylation of CX43 was negatively regulated by the phosphorylation of ERK and JNK. Also, our data could provide some new evidence of how to leverage the endogenous astrocytes phenotype changes during CNS injury by promoting them to be “protector” and not “culprit”.
format Article
id doaj-art-2eabdff08c0b44edb46e7f4d8059da90
institution Kabale University
issn 2076-3425
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj-art-2eabdff08c0b44edb46e7f4d8059da902024-12-27T14:14:55ZengMDPI AGBrain Sciences2076-34252024-12-011412125610.3390/brainsci14121256The Phenotype Changes of Astrocyte During Different Ischemia ConditionsFei Meng0Jing Cui1Peng Wang2Junhui Wang3Jing Sun4Liang Li5Cardiac Valve Center, Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 101100, ChinaDepartment of Pathology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaThe Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital, Shandong University, Jinan 250012, ChinaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, CanadaDepartment of Pathology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Pathology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaObjectives: Dementia is becoming a major health problem in the world, and chronic brain ischemia is an established important risk factor in predisposing this disease. Astrocytes, as one major part of the blood–brain barrier (BBB), are activated during chronic cerebral blood flow hypoperfusion. Reactive astrocytes have been classified into phenotype pro-inflammatory type A1 or neuroprotective type A2. However, the specific subtype change of astrocyte and the mechanisms of chronic brain ischemia are still unknown. Methods: In order to depict the phenotype changes and their possible roles during this process, a rat bilateral common carotid artery occlusion model (BCAO) was employed in the present study. Meanwhile, the signaling pathways that possibly regulate these changes were investigated as well. Results: After four-week occlusion, astrocytes in the cortex of BCAO rats were shown to be the A2 phenotype, identified by the significant up-regulation of S100a10 accompanied by the down-regulation of Connexin 43 (CX43) protein. Next, we established in vitro hypoxia models, which were set up by stimulating primary astrocyte cultures from rat cortex with cobalt chloride, low glucose, or/and fibrinogen. Consistent with in vivo data, the cultured astrocytes also transformed into the A2 phenotype with the up-regulation of S100a10 and the down-regulation of CX43. In order to explore the mechanism of CX43 protein changes, C6 astrocyte cells were handled in both hypoxia and low-glucose stimulus, in which decreased pERK and pJNK expression were found. Conclusions: In conclusion, our data suggest that in chronic cerebral ischemia conditions, the gradual ischemic insults could promote the transformation of astrocytes into A2 type instead of A1 type, and the phosphorylation of CX43 was negatively regulated by the phosphorylation of ERK and JNK. Also, our data could provide some new evidence of how to leverage the endogenous astrocytes phenotype changes during CNS injury by promoting them to be “protector” and not “culprit”.https://www.mdpi.com/2076-3425/14/12/1256dementiaischemiaastrocytesA2 phenotypeConnexin 43
spellingShingle Fei Meng
Jing Cui
Peng Wang
Junhui Wang
Jing Sun
Liang Li
The Phenotype Changes of Astrocyte During Different Ischemia Conditions
Brain Sciences
dementia
ischemia
astrocytes
A2 phenotype
Connexin 43
title The Phenotype Changes of Astrocyte During Different Ischemia Conditions
title_full The Phenotype Changes of Astrocyte During Different Ischemia Conditions
title_fullStr The Phenotype Changes of Astrocyte During Different Ischemia Conditions
title_full_unstemmed The Phenotype Changes of Astrocyte During Different Ischemia Conditions
title_short The Phenotype Changes of Astrocyte During Different Ischemia Conditions
title_sort phenotype changes of astrocyte during different ischemia conditions
topic dementia
ischemia
astrocytes
A2 phenotype
Connexin 43
url https://www.mdpi.com/2076-3425/14/12/1256
work_keys_str_mv AT feimeng thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT jingcui thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT pengwang thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT junhuiwang thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT jingsun thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT liangli thephenotypechangesofastrocyteduringdifferentischemiaconditions
AT feimeng phenotypechangesofastrocyteduringdifferentischemiaconditions
AT jingcui phenotypechangesofastrocyteduringdifferentischemiaconditions
AT pengwang phenotypechangesofastrocyteduringdifferentischemiaconditions
AT junhuiwang phenotypechangesofastrocyteduringdifferentischemiaconditions
AT jingsun phenotypechangesofastrocyteduringdifferentischemiaconditions
AT liangli phenotypechangesofastrocyteduringdifferentischemiaconditions